BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32620520)

  • 1. A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.
    Pereira PL; Arnold D; de Baère T; Gomez F; Helmberger T; Iezzi R; Maleux G; Prenen H; Sangro B; Nordlund A; Zeka B; Bauer R; Kaufmann N; Pellerin O; Taieb J
    Dig Liver Dis; 2020 Aug; 52(8):857-861. PubMed ID: 32620520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis.
    Pereira PL; Iezzi R; Manfredi R; Carchesio F; Bánsághi Z; Brountzos E; Spiliopoulos S; Echevarria-Uraga JJ; Gonçalves B; Inchingolo R; Nardella M; Pellerin O; Sousa M; Arnold D; de Baère T; Gomez F; Helmberger T; Maleux G; Prenen H; Sangro B; Zeka B; Kaufmann N; Taieb J
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):50-62. PubMed ID: 32974773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
    Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
    World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
    BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.
    Fereydooni A; Letzen B; Ghani MA; Miszczuk MA; Huber S; Chapiro J; Schlachter T; Geschwind JF; Georgiades C
    J Vasc Interv Radiol; 2018 Dec; 29(12):1646-1653.e5. PubMed ID: 30337148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
    Ishikawa T; Imai M; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
    Anticancer Res; 2023 Aug; 43(8):3647-3651. PubMed ID: 37500124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
    Mauri G; Varano GM; Della Vigna P; Bonomo G; Monfardini L; Zampino MG; Ravenda PS; Orsi F
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1708-1715. PubMed ID: 29951693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
    Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Tolerability of Topotecan-Eluting Radiopaque Microspheres for Hepatic Chemoembolization in a Rabbit Preclinical Model.
    Mikhail AS; Levy EB; Krishnasamy VP; Woods DL; Esparza-Trujillo JA; Bakhutashvili I; Banovac F; Wakim PG; Negussie AH; Tang Y; Henman A; Willis SL; Karanian JW; Pritchard WF; Lewis AL; Wood BJ
    Cardiovasc Intervent Radiol; 2020 Dec; 43(12):1918-1924. PubMed ID: 32803282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
    Ngo A; von Stempel C; Corbo B; Bandula S; Shiu KK; Raja J; Hague J; Evans J; Kibrya N
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):979-990. PubMed ID: 31044294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LifePearl microspheres loaded with irinotecan in the treatment of Liver-dominant metastatic colorectal carcinoma: feasibility, safety and pharmacokinetic study.
    Maleux G; Prenen H; Helmberger T; Spriet I; Isailovic TV; Pereira P
    Anticancer Drugs; 2020 Nov; 31(10):1084-1090. PubMed ID: 32932279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
    Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
    Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
    Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
    In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
    Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
    Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30-60 μm Microspheres Loaded with Irinotecan.
    Malagari K; Kiakidis T; Moschouris H; Charokopakis A; Vergadis C; Alevisopoulos N; Kartsouni V; Panagiotou I; Pellerin O; Glantzounis G; Filippiadis DK; Emmanouil E; Tsavaris N; Psarros G; Delicha E; Kelekis N
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):880-890. PubMed ID: 37337059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
    Aliberti C; Tilli M; Benea G; Fiorentini G
    Anticancer Res; 2006; 26(5B):3793-5. PubMed ID: 17094403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.